We provide ongoing monitoring, encouragement, and accountability through follow-up appointments, progress tracking, and access to a network of healthcare professionals and resources
The oral form uses a SNAC (sodium N-[8-(2-hydroxybenzoyl)amino]caprylate) absorption enhancer to allow GLP-1 passage through the gastric mucosa, achieving approximately 1% bioavailability compared to subcutaneous injection
What to monitor: Intensified GI symptoms (the 2 to 4 mg jump is significant)
Track your weight daily but evaluate weekly averages to distinguish true plateaus from normal fluctuation
IGF-1 LR3 is legal to purchase from licensed peptide suppliers for documented research purposes only
Misuse and abuse: Pills may be easier to conceal, share, or overuse than injectables